Hypertension as a Major Risk Factor in Diabetic Patients on Hemodialysis and CAPD

  • E. Ritz
  • C. Hasslacher
  • W. Tschöpe
Conference paper


The magnitude of the problem of hypertension in diabetic patients is illustrated by Fig. 1. In Type I diabetics with no proteinuria, the prevalence of hypertension is higher than in age- and sex-matched cohorts of the general population. Hypertension increases in progressively more advanced stages of nephropathy. Even more striking is the high prevalence of hypertension in nonproteinuric Type II diabetics, an observation which may be related — at least in part — to the possible role of insulin in raising blood pressure as recently discussed by many authors. The prevalence of hypertension increases with progressive severity of nephropathy such as occurs in Type I diabetics.


Diabetic Patient Diabetic Nephropathy Metabolic Control Uremic Patient Raise Blood Pressure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hasslacher C, Stech W, Wahl P, Ritz E (1985) Blood pressure and metabolic control as risk factors for nephropathy in type I (insulin-dependent) diabetes. Diabetologia 28: 6PubMedCrossRefGoogle Scholar
  2. 2.
    Hasslacher C, Terpstra J, Kunowski G, Gallasch G, Ritz E (1986) Metabolie control and blood pressure as risk factors for proliferative retinopathy in proteinuric type I diabetics. Transplant Proc XVIII: 1572–1573Google Scholar
  3. 3.
    Hasslacher C, Ritz E, Terpstra J, Gallasch G, Kunowski G, Rail C (1985) Natural history of nephropathy in type I diabetes. Relationship to metabolic control and blood pressure. Hypertension 7 [Suppl II): II-74-II-78Google Scholar
  4. 4.
    Hasslacher C, Wolfram M, Stech G, Wahl P, Ritz E (1987) Einfluß von Stoffwechseleinstellung und Blutdruck auf die Entwicklung der diabetischen Retinopathie beim Typ II Diabetes. Dtsch Med Wochenschr (in press)Google Scholar
  5. 5.
    Hasslacher C, Wahl P, Ritz E (1987) Similar risks of nephropathy in type I and type II diabetes (abstract). In: 20th Annual Meeting of the Society of Nephrologists, Washington DCGoogle Scholar
  6. 6.
    Ritz E, Hasslacher C, Tschöpe W, Koch M, Mann JFE (1987) Hypertension in diabetes mellitus. Contrib Nephrol 54: 77–86PubMedGoogle Scholar
  7. 7.
    Mogensen CE (1976) Progression of nephropathy in long-term diabetics with proteinuria and effect of initial antihypertensive treatment. Scand J Clin Lab Invest 36: 384CrossRefGoogle Scholar
  8. 8.
    Anderson S, Rennke HG, Breuner B (1986) Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 77: 1993–2000PubMedCrossRefGoogle Scholar
  9. 9.
    Reisch C, Mann J, Ritz E (1987) Konversionsenzymhemmer in der antihypertensiven Behand-lung niereninsuffizienter Patienten. Dtsch Med Wochenschr 112: 1249–1252PubMedCrossRefGoogle Scholar
  10. 10.
    Challah S, Brunner FP, Wing AJ (1987) Evolution of the treatment of patients with diabetic nephropathy by renal replacement therapy in Europe over a decade. Data from the EDTA Registry. In: Mogensen CE (ed) Diabetes mellitus and the kidney. Nijhoff, (in press)Google Scholar
  11. 11.
    Strumpf C, Katz F, Wing AJ, Ritz E (1984) Cardiovascular risk factors and cardiovascular death in haemodialysed diabetic patients. Proc Eur Dial Transplant Assoc Eur Ren Assoc 21: 202–209Google Scholar
  12. 12.
    Ritz E, Strumpf C, Katz F, Wing AJ, Quellhorst E (1985) Hypertension and cardiovascular risk factors in hemodialyzed diabetic patients. Hypertension 7 [Suppl II]: II-118-II-124Google Scholar
  13. 13.
    Wing AJ, Brunner FP, Brynger H, Jacobs C, Kramer P, Selwood NH, Gretz N (1984) Car- diovascular-related causes of death and the fate of patients with renovascular disease. Contrib Nephrol 41: 306–311PubMedGoogle Scholar
  14. 14.
    Hasslacher C, Rambausek M, Ritz E (1983) Genesis and management of hypertension in diabetic nephropathy. In: Keen H, Legrain M (eds) Prevention and treatment of diabetic nephropathy. MTP Press, Boston, pp 177–189Google Scholar
  15. 15.
    Chou LM, Beyer MM, Butt KM, Manis T, Friedman EA (1984) Hypertension jeopardizes diabetic patients following renal transplant. Trans Am Soc Artif Intern Org 30: 473–478Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • E. Ritz
  • C. Hasslacher
  • W. Tschöpe

There are no affiliations available

Personalised recommendations